143 related articles for article (PubMed ID: 25294054)
1. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma.
Kontić M; Milovanović J; Čolović Z; Poljak NK; Šundov Ž; Sučić A; Pešutić-Pisac V
Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):401-5. PubMed ID: 25294054
[TBL] [Abstract][Full Text] [Related]
2. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
3. Association between EGFR expression and clinical outcome of laryngeal HPV squamous cell carcinoma.
Kontić M; Čolović Z; Paladin I; Gabelica M; Barić A; Pešutić-Pisac V
Acta Otolaryngol; 2019 Oct; 139(10):913-917. PubMed ID: 31430224
[No Abstract] [Full Text] [Related]
4. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx.
Şimşek H; Han Ü; Önal B; Şimişek G
Turk J Med Sci; 2014; 44(3):411-6. PubMed ID: 25558642
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
7. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
10. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression.
Lee CS; Redshaw A; Boag G
Aust N Z J Surg; 1996 Jul; 66(7):464-8. PubMed ID: 8678876
[TBL] [Abstract][Full Text] [Related]
11. Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Head Neck; 2016 Oct; 38(10):1539-44. PubMed ID: 27312568
[TBL] [Abstract][Full Text] [Related]
12. MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma.
Vivatvakin S; Ratchataswan T; Leesutipornchai T; Ruangritchankul K; Keelawat S; Mahattanasakul P; Bongsebandhu-Phubhakdi S
Sci Rep; 2021 Jul; 11(1):14607. PubMed ID: 34272446
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].
Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019
[TBL] [Abstract][Full Text] [Related]
14. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
15. Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma.
Marijić B; Braut T; Babarović E; Krstulja M; Maržić D; Avirović M; Kujundžić M; Hadžisejdić I
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):576-584. PubMed ID: 33758141
[TBL] [Abstract][Full Text] [Related]
16. Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role.
Puzzo L; Caltabiano R; Parenti R; Trapasso S; Allegra E
Head Neck Pathol; 2016 Sep; 10(3):292-7. PubMed ID: 26748803
[TBL] [Abstract][Full Text] [Related]
17. [Relation between epidermal growth factor receptor (EGFR) and p53 expression and radiocurability of laryngeal squamous cell cancer].
Dupla D; Fraczek M; Woźniak Z; Krecicki T
Otolaryngol Pol; 2009; 63(3):249-55. PubMed ID: 19886531
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of integrin-linked kinase in laryngeal squamous cell carcinoma.
Wu PA; Li SS; Tang QL; Liu BB; Yang XM
Auris Nasus Larynx; 2017 Aug; 44(4):458-463. PubMed ID: 28188026
[TBL] [Abstract][Full Text] [Related]
19. Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab.
Almadori G; Lauriola L; Coli A; Bussu F; Gallus R; Scannone D; Valentini V; Paludetti G; Carey TE; Ranelletti FO
Head Neck; 2017 Apr; 39(4):684-693. PubMed ID: 28032719
[TBL] [Abstract][Full Text] [Related]
20. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation.
Kourelis K; Vandoros G; Kourelis T; Goumas P; Sotiropoulou-Bonikou G
J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):233-9. PubMed ID: 19442374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
